Macular degeneration dependent on defense mechanisms conditioned by chemical elements and genetic polymorphism

Piotr Kamiński1,2, Sylwia Brodzka3, Jędrzej Baszyński4

  • 1Faculty of Medicine, Department of Medical Biology and Biochemistry, Division of Ecology and Environmental Protection, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, M. Skłodowska-Curie St. 9, PL 85-094, Bydgoszcz, Poland. piotr.kaminski@cm.umk.pl.

Scientific Reports
|July 4, 2026
PubMed

Insights

This study reveals that environmental factors and genetic predispositions significantly influence the development of wet age-related macular degeneration (MD). Researchers identified key biomarkers and genetic factors contributing to MD, offering new avenues for understanding and potentially preventing this eye disease.

Area of Science:

  • Ophthalmology
  • Environmental Health
  • Genetics

Background:

  • Macular degeneration (MD) is a growing concern, increasingly affecting younger individuals, with oxidative stress identified as a critical factor.
  • The wet form of MD, the focus of this study, involves complex interactions between environmental exposures and genetic predispositions.

Purpose of the Study:

  • To investigate the role of environmental toxic metals, macroelements, and microelements in the development of exudative MD.
  • To assess the activity of antioxidant enzymes and nonenzymatic mechanisms in relation to MD.
  • To examine the influence of specific genetic polymorphisms (GSTT1, GSTM1, IL-4, VEGF-A) on MD development.

Main Methods:

  • Analysis of whole blood and plasma from 84 exudative MD patients and 127 healthy controls using ICP-MS for elemental concentrations.
  • Measurement of antioxidant enzyme activities (SOD, CAT, GPx, GR) and nonenzymatic antioxidants (GSH, bilirubin, uric acid, vitamins A and E).
  • Assessment of lipoperoxidation (MDA), ceruloplasmin (CP) levels, and genetic polymorphisms (GSTT1, GSTM1, IL-4, VEGF-A).

Main Results:

  • Significant differences in elemental profiles (e.g., P, Ca, Mn, Fe, Cu, Zn in MD patients vs. Pb, Ca, Mn, Zn, Ba in controls) and antioxidant parameters (SOD, CAT, GPx, bilirubin, vitamins A and E, uric acid) were observed between groups.
  • Malondialdehyde (MDA) and ceruloplasmin (CP) showed low diagnostic value for MD.
  • Significant differences in IL-4 allele frequency and all-trans retinol levels were noted, while GSTT1, GSTM1, and VEGF-A polymorphisms did not show significant group differences.

Conclusions:

  • Environmental factors and genetic changes play a crucial role in MD pathogenesis, detectable through enzymatic and nonenzymatic mechanisms.
  • New parameters such as Na, P, Cr, Mn, Ba, MDA, bilirubin, vitamins A and E, SOD, CAT, GPx, and IL-4 are identified as important for assessing MD predisposition.
  • Further research is needed to elucidate the roles of various elements (K, Pb, As, Hg, Cd, Sr, Al, Ba, V, Fe) and genetic mutations (IL-4, GSTM1, GSTT1) in MD development.

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genetic Lingo01:11

Genetic Lingo

Overview
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...